BLUEPRINT MEDICINES CORP's ticker is BPMC and the CUSIP is 09627Y109. A total of 217 filers reported holding BLUEPRINT MEDICINES CORP in Q1 2020. The put-call ratio across all filers is 0.91 and the average weighting 0.3%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $63,611,395 | -17.6% | 1,266,497 | +3.7% | 0.01% | -11.1% |
| Q2 2023 | $77,179,418 | +47.6% | 1,221,193 | +5.0% | 0.01% | +28.6% |
| Q1 2023 | $52,307,189 | +107045.1% | 1,162,640 | +4.3% | 0.01% | 0.0% |
| Q4 2022 | $48,819 | -99.9% | 1,114,337 | +3.6% | 0.01% | -36.4% |
| Q3 2022 | $70,851,000 | +33.7% | 1,075,293 | +2.5% | 0.01% | +37.5% |
| Q2 2022 | $52,982,000 | -20.0% | 1,048,949 | +1.2% | 0.01% | 0.0% |
| Q1 2022 | $66,218,000 | -40.0% | 1,036,608 | +0.6% | 0.01% | -38.5% |
| Q4 2021 | $110,315,000 | +5.9% | 1,029,931 | +1.7% | 0.01% | -7.1% |
| Q3 2021 | $104,151,000 | +15.8% | 1,013,050 | -0.9% | 0.01% | +16.7% |
| Q2 2021 | $89,912,000 | -4.3% | 1,022,201 | +5.8% | 0.01% | -14.3% |
| Q1 2021 | $93,972,000 | -3.2% | 966,496 | +11.6% | 0.01% | -12.5% |
| Q4 2020 | $97,117,000 | +27.7% | 865,962 | +5.5% | 0.02% | +6.7% |
| Q3 2020 | $76,078,000 | +18.5% | 820,698 | -0.3% | 0.02% | +7.1% |
| Q2 2020 | $64,217,000 | +38.4% | 823,304 | +3.7% | 0.01% | +16.7% |
| Q1 2020 | $46,409,000 | -58.1% | 793,609 | -42.6% | 0.01% | 0.0% |
| Q4 2019 | $110,762,000 | +127.8% | 1,382,636 | +109.0% | 0.01% | +9.1% |
| Q3 2019 | $48,615,000 | -21.1% | 661,706 | +1.3% | 0.01% | -26.7% |
| Q2 2019 | $61,628,000 | +43.4% | 653,327 | +21.7% | 0.02% | +36.4% |
| Q1 2019 | $42,980,000 | -19.1% | 536,923 | -45.5% | 0.01% | +37.5% |
| Q4 2018 | $53,118,000 | +47.2% | 985,324 | +113.2% | 0.01% | -20.0% |
| Q3 2018 | $36,076,000 | +39.4% | 462,163 | +13.3% | 0.01% | +25.0% |
| Q2 2018 | $25,887,000 | -25.0% | 407,811 | +8.3% | 0.01% | -27.3% |
| Q1 2018 | $34,515,000 | +23.9% | 376,396 | +1.9% | 0.01% | +22.2% |
| Q4 2017 | $27,855,000 | +19.7% | 369,391 | +10.6% | 0.01% | 0.0% |
| Q3 2017 | $23,265,000 | +45.3% | 333,936 | +5.6% | 0.01% | +50.0% |
| Q2 2017 | $16,016,000 | +57.7% | 316,092 | +24.4% | 0.01% | +50.0% |
| Q1 2017 | $10,158,000 | +58.9% | 254,026 | +11.5% | 0.00% | +33.3% |
| Q4 2016 | $6,392,000 | +26.8% | 227,898 | +34.3% | 0.00% | 0.0% |
| Q3 2016 | $5,040,000 | +158.3% | 169,729 | +76.1% | 0.00% | +200.0% |
| Q2 2016 | $1,951,000 | +50.5% | 96,381 | +34.2% | 0.00% | 0.0% |
| Q1 2016 | $1,296,000 | -29.5% | 71,813 | +2.9% | 0.00% | 0.0% |
| Q4 2015 | $1,838,000 | +26.5% | 69,802 | +2.5% | 0.00% | 0.0% |
| Q3 2015 | $1,453,000 | – | 68,108 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Aquilo Capital Management, LLC | 423,012 | $41,129,000 | 7.43% |
| Eagle Health Investments LP | 133,163 | $12,947,000 | 5.08% |
| DAFNA Capital Management LLC | 207,911 | $20,215,000 | 4.80% |
| Casdin Capital, LLC | 1,550,000 | $150,707,000 | 4.49% |
| SIB LLC | 65,151 | $6,335,000 | 3.72% |
| CADIAN CAPITAL MANAGEMENT, LP | 913,702 | $88,839,000 | 3.29% |
| Integral Health Asset Management, LLC | 117,500 | $11,425,000 | 3.26% |
| Rock Springs Capital Management LP | 746,732 | $72,605,000 | 1.58% |
| Avidity Partners Management LP | 546,000 | $53,088,000 | 1.47% |
| Zebra Capital Management LLC | 12,698 | $1,235,000 | 1.36% |